Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
This disclosure provides methods, systems, and compositions of matter for studying solvent accessibility and three-dimensional structure of biological molecules. A plasma can be used to generate marker radicals, which can interact with a biological molecule and mark the solvent-accessible portions of the biological molecule.
1 . A system for modifying a biological molecule, the system comprising:
a sample chamber configured to contain a sample including a biological molecule, the sample chamber comprising a chemically and biologically inert inner surface;
a plasma electrode;
a power supply; and
a control system in electronic communication with the power supply and the plasma electrode, wherein the control system is configured to cause the system to generate a plasma;
wherein the plasma is generated such that, when the sample chamber contains the sample, one or more of a plurality of marker radical precursors is converted into one or more marker radicals to interact with the biological molecule,
wherein the generating the plasma causes a detectable difference in the biological molecule without elevating a temperature of the sample by an amount that initiates denaturation of the biological molecule.
2 . The system of claim 1 , wherein the control system is configured to cause the system to generate a sequence of plasma pulses.
3 . The system of claim 2 , wherein the plasma pulses have a pulse width of between 1 ps and 1 ms, the sequence of plasma pulses have a frequency of between 1 Hz and 100 GHz, or the sequence of plasma pulses are generated for a total length of time of between 1 ns and 1 hour.
4 . The system of claim 1 , wherein the control system is configured to cause the system to generate the plasma with a voltage of between 1 V and 1 MV.
5 . The system of claim 1 , wherein the plasma is configured to provide a peak concentration of marker radicals in the sample of between 50 nM and 800 μM.
6 . The system of claim 1 , wherein the plasma is configured to transfer an amount of energy to the sample of less than 360 MJ.
7 . The system of claim 1 , wherein the sample chamber is adapted to receive a sample having a volume of between 1 μL and 400 L.
8 . The system of claim 1 , the system comprising a plurality of additional sample chambers, each configured to contain a respective additional sample including a respective additional biological molecule, each comprising a respective additional chemically and biologically inert inner surface, and the control system is configured to cause the system to generate the plasma or a plurality of additional plasmas such that, when each of the plurality of additional sample chambers contains the respective additional sample, the plasma or plurality of additional plasmas converts one or more of an additional plurality of marker radical precursors into one or more additional marker radicals to interact with the respective additional biological molecule.
9 . The system of claim 1 , the system further comprising an amplifier located between the power supply and the plasma electrode and configured to amplify the voltage at the plasma electrode.
10 . The system of claim 1 , the system further comprising a protective housing encompassing at least the sample chamber and the plasma electrode.
11 . The system of claim 10 , wherein the protective housing is hermetically sealed.
12 . The system of claim 10 , wherein the protective housing has an inlet coupled to a gas manifold configured to control gas composition and pressure within the protective housing.
13 . The system of claim 10 , wherein the protective housing has a door configured to provide access to an interior of the protective housing, the door having a lock in electronic communication with the control system, the control system configured to fasten the lock during operation of the system.
14 . The system of claim 1 , wherein the control system is configured to generate the plasma with a time resolution of at least 100 ms.
15 . The system of claim 1 , wherein the control system is configured to generate the plasma with a time resolution of at least 1 ms.
16 . The system of claim 1 , wherein the sample chamber is thermally coupled to a convective cooling device.
17 . The system of claim 16 , wherein the convective cooling device is a Peltier cooler.
18 . The system of claim 1 , wherein the plasma electrode is a plasma jet.
19 . A system for modifying a biological molecule, the system comprising:
a sample chamber configured to contain a sample including a biological molecule, the sample chamber comprising a chemically and biologically inert inner surface;
a plasma electrode;
a power supply; and
a control system in electronic communication with the power supply and the plasma electrode, the control system configured to utilize electrical power from the power supply with the plasma electrode to generate a plasma;
wherein the plasma is generated such that, when the sample chamber contains the sample, one or more of a plurality of marker radical precursors is converted into one or more marker radicals to interact with the biological molecule,
wherein the generating the plasma causes a detectable difference in the biological molecule without elevating temperature of the sample by an amount that initiates denaturation of the biological molecule.
20 . A system for modifying a biological molecule, the system comprising:
a sample chamber configured to contain a sample including a biological molecule, the sample chamber comprising a chemically and biologically inert inner surface;
a plasma electrode;
a power supply; and
a control system in electronic communication with the power supply and the plasma electrode, the control system configured to utilize electrical power from the power supply with the plasma electrode to generate a sequence of plasma pulses;
wherein the sequence of plasma pulses is generated such that, when the sample chamber contains the sample, one or more of a plurality of marker radical precursors is converted into one or more marker radicals to interact with the biological molecule,
wherein the generating the plasma causes detectable difference in the biological molecule without elevating temperature of the sample by an amount that initiates denaturation of the biological molecule.